Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-017-0235-x
Published Online: 2017-02-14
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kalra, Sanjay
Text and Data Mining valid from 2017-02-14
Article History
Received: 6 January 2017
First Online: 14 February 2017